Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 AbbVie 2 Daiichi Sankyo 2
Trials & R&D · first seen yesterday, updated yesterday

Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency

1 outlet

Coverage 1 article · 1 outlet

  1. Seeking Alpha Healthcare
    Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency